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ARTICLE
PHD1 controls muscle mTORC1 in a hydroxylation-
independent manner by stabilizing leucyl tRNA
synthetase
Gommaar D’Hulst1,13, Inés Soro-Arnaiz1,13, Evi Masschelein1, Koen Veys 2,3, Gillian Fitzgerald1,
Benoit Smeuninx4,5, Sunghoon Kim 6, Louise Deldicque7, Bert Blaauw8, Peter Carmeliet 2,3,
Leigh Breen4,5, Peppi Koivunen9, Shi-Min Zhao10,11,12 & Katrien De Bock 1*
mTORC1 is an important regulator of muscle mass but how it is modulated by oxygen and
nutrients is not completely understood. We show that loss of the prolyl hydroxylase domain
isoform 1 oxygen sensor in mice (PHD1KO) reduces muscle mass. PHD1KO muscles show
impaired mTORC1 activation in response to leucine whereas mTORC1 activation by growth
factors or eccentric contractions was preserved. The ability of PHD1 to promote mTORC1
activity is independent of its hydroxylation activity but is caused by decreased protein content
of the leucyl tRNA synthetase (LRS) leucine sensor. Mechanistically, PHD1 interacts with and
stabilizes LRS. This interaction is promoted during oxygen and amino acid depletion and
protects LRS from degradation. Finally, elderly subjects have lower PHD1 levels and LRS
activity in muscle from aged versus young human subjects. In conclusion, PHD1 ensures an
optimal mTORC1 response to leucine after episodes of metabolic scarcity.
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Skeletal muscle mass is essential to life as it providesmechanical power for movement and at the same time playsa crucial role in whole body metabolism. From the age of
50, skeletal muscle mass is lost at a rate of 1–2% per year1,
resulting in diminished functional strength that correlates with
lower overall quality of life and increased mortality2,3. Muscle is
also critical component of diseases such as chronic obstructive
pulmonary disorder, diabetes, cancer, anemia, and sepsis4–6. The
clinical and financial burden of loss of muscle mass to society is
enormous7, and it is therefore vital to develop strategies to pre-
vent loss of muscle mass, or to maintain and even increase muscle
mass. To do so, we need to improve our understanding of the
underlying molecular mechanisms that control skeletal muscle
mass.
Skeletal muscle mass is defined by a fine balance between
protein synthesis and breakdown8,9, processes which are gov-
erned by mechanistic target of rapamycin complex 1 (mTORC1),
a master regulator of cellular metabolism10. Growth factors,
energetic stress, and contractions control mTORC1 directly or
via its upstream inhibitor tuberous sclerosis complex 1/2
(TSC1/2)11,12. Amino acids regulate mTORC1 via alternative
pathways involving Rag GTPases, which recruit mTORC1 to the
lysosomal membrane13,14. How TSC2-dependent signals regulate
mTORC1 in skeletal muscle has been intensely studied11,15,16, but
how fluctuations of amino acids, and in particular the essential
amino acid leucine, regulate mTORC1, and thus skeletal muscle
mass in vivo is much less well understood.
Over the last years, intense research efforts have led to the
discovery of leucine sensors, such as SESTRINs (SESNs) and
leucyl-tRNA synthetase (LRS), which transmit intracellular leu-
cine availability toward mTORC117,18. SESNs negatively regulate
mTORC1 by binding and inhibiting GATOR2, an upstream
activator of mTORC119. Upon leucine stimulation, SESN2 dis-
sociates from GATOR2 resulting in increased mTORC1 activa-
tion17. LRS, an aminoacyl tRNA synthetase that catalyzes the
ligation of leucine to its cognate tRNA20, also exerts a non-
canonical role and activates mTORC1 upon leucine binding by
functioning as a GAP toward RagD and by ensuring the leucy-
lation of RagA/B18,21. Besides their sensing activities, it is plau-
sible that alterations in protein levels of leucine sensors can
impose an additional level of control on mTORC1 activity22. For
instance, amino acid starvation and stress upregulate SESN2
protein content23,24, and lead to more SESN2 bound to GATOR2
and thus sustained mTORC1 inhibition. Whether fluctuations in
nutrient availability also affect the levels or stability of LRS and
whether dynamic changes in LRS content can regulate mTORC1
activity remains to be elucidated.
De novo protein synthesis is a highly energy consuming pro-
cess25, while the energy cost of protein breakdown has been
estimated to be much lower to even neglectable26. Protein
synthesis and mTORC1 activity therefore need to be tightly
controlled upon metabolic stress such as hypoxia and nutrient
deprivation, to ensure cell survival. Dependent on the specific
context, hypoxia either strongly inhibits or promotes mTORC1
activity27–30. Yet, the cellular machinery that ensures cell survival
and orchestrates a fast and efficient cellular recovery upon
restoration of oxygen and nutrient supply needs to be maintained.
An excellent set of candidates to orchestrate such adaptive
responses are prolyl-hydroxylase domain proteins 1–3 (PHD1–3).
PHDs belong to a family of enzymes which use oxygen, Fe2+,
ascorbic acid, and the TCA intermediate α-ketoglutarate (αKG) to
hydroxylate proline residues in their target substrate proteins, the
best characterized ones being the hypoxia-inducible factors 1–3α
(HIF1–3α)31,32. During hypoxia, HIF1α inhibits mTORC1 by
activating the transcription its downstream target regulated in
development and DNA damage response 1 (REDD1) which has
been shown to activate TSC215,33. On the other hand, HIF2α
increases mTORC1 activity under low amino acid availability by
increasing the expression of the LAT1 amino acid carrier29.
Besides controlling HIF stability, PHDs can also change the
activity and stability of other proteins, either or not in a hydro-
xylation dependent fashion34. But whether PHDs can directly
control protein synthesis, is not known.
Here, we show that PHD1 controls the activation of mTORC1
in response to leucine in a hydroxylation-independent manner.
PHD1 interacts with and determines the stability of the leucine
sensor LRS. This interaction is promoted under conditions of
hypoxia and amino acid starvation (when PHD1 activity is
inhibited) and protects LRS from degradation. In this way, PHD1
ensures effective activation of mTORC1 in response to leucine. As
a consequence, genetic loss of Phd1 reduces the stability of LRS,
impaires leucine mediated activation of mTORC1 and leads to
lower muscle mass. The relevance of our data is underscored by
the observation that elderly humans have lower PHD1 levels and
LRS activity in muscle.
Results
Phd1-deficient mice have lower muscle mass. To study the role
of PHD1 in mTORC1 activation and muscle mass control in vivo
we used PHD1KO mice (50% Swiss/50% 129S1)35. Both males
(Fig. 1a) and females (Supplementary Fig. 1a) showed lower mass
of both m. gastrocnemius (GAS), m. tibialis anterior (TA) and m.
extensor digitorum longus (EDL). Magnetic resonance imaging
(MRI) analysis confirmed that PHD1KO mice have lower lean
mass when compared with the corresponding controls (Fig. 1b).
The reduction in lean mass resulted into lower body weight in
males but not in females (Fig. 1d and Supplementary Fig. 1d),
where the reduction in lean mass was completely compensated by
an increase in fat mass (Supplementary Fig. 1c). This data con-
firms previous work reporting increased white adipose tissue
mass in PHD1KO mice36. Analysis of fiber area in TA showed that
lower muscle weight was accompanied with decreased fiber cross-
sectional area (Fig. 1e). Differences in fiber cross-sectional area
were not secondary to a shift in muscle fiber type composition
(Supplementary Fig. 1e). We also did not find evidence for overt
myopathy, indicated by the absence of centrally nucleated fibers
(Supplementary Fig. 1f). Absolute force–frequency analysis of
ex vivo contracted soleus showed reduced force production in
PHD1KO compared to WT mice (Fig. 1f). Relative
force–frequency, which is corrected for muscle surface area, was
unaffected (Supplementary Fig. 1h), further confirming that the
lower force production in these muscles was caused by lower fiber
area and likely not by defective intrinsic mechanical capacities.
Since muscle fiber size is determined by the balance between
protein synthesis and protein breakdown, we first monitored the
status of the ubiquitin-proteasome and autophagy-lysosome
systems, the two main contributors to muscle protein break-
down37. RT-qPCR analysis failed to show increased expression of
the ubiquitin-proteasome related genes Atrogin-1, Murf1, Itch,
Smart, Musa1, and FbxO31 (Fig. 1g). mRNA levels of autophagy
related genes such as P62, Lc3b, GabarapL, Bnip3, and CathL
were also not affected by loss of Phd1 (Supplementary Fig. 1g).
Accordingly, expression of microtubule-associated protein 1 light
chain 3 (LC3-I) and lipidated LC3 (LC3-II) was not different
between PHD1KO compared to WT muscles which were
harvested after 4 h of food withdrawal (Fig. 1h), neither did we
find differences in P62 protein content, a marker for autophagy
impairment (Fig. 1h). This data indicates that loss of Phd1 does
not substantially promote muscle protein breakdown and
prompted us to evaluate whether PHD1 controls muscle protein
synthesis.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13889-6
2 NATURE COMMUNICATIONS |          (2020) 11:174 | https://doi.org/10.1038/s41467-019-13889-6 | www.nature.com/naturecommunications
WT
PHD1KO
*
*
*
**
**
*
*
* *
WT
PHD1KO
PHD1KO
PHD1KO
WT
PHD1KO
p = 0.06
**
WT
PHD1KO
*
***
p  = 0.27
ns ns
*
WT PHD1KOWT
LC
3B
 II
/L
C3
B 
I
1.5
1.0
0.5
0.0
P6
2/
lo
ad
in
g
2.0
1.0
0.0
h
LC3B III
P62
– + – +
Loading
Fo
rc
e 
(m
N)
200
100
150
50
0
0 100 200 300
Frequency (Hz)
f g
Atrogin1 Murf Itch Smart Musa FbxO31
m
R
N
A 
ex
pr
es
sio
n 
le
ve
ls
3
2
1
0
e
Fiber cross-sectional area (µm2)
< 
50
0
50
0–
10
00
10
00
–1
50
0
15
00
–2
00
0
20
00
–2
50
0
25
00
–3
00
0
30
00
–3
50
0
35
00
–4
00
0
40
00
–4
50
0
45
00
–5
00
0
> 
55
00
30
20
10
0
To
ta
l c
ou
nt
 (%
)
50 μm
WT
50 μm
Soleus EDL GAS TA
200
150
100
60
40
20
0
M
us
cl
e 
w
ei
gh
t (m
g)
a
Bo
dy
 w
ei
gh
t (g
)
d
40
30
20
10
0
b
100
75
50
25
0
WT PHD1KO WT PHD1KO
PHD1KO
WT PHD1KO
Le
an
 m
as
s 
(%
)
c
100
75
50
25
0
Fa
t m
as
s 
(%
)
10
75
KDa
Fig. 1 Phd1-deficient mice have lower muscle mass. Bar graphs showing muscle weight (a), lean mass (b), fat mass (c), and body weight (d) of WT (white
bars) and PHD1KO (red bars) male mice. e Quantification (left panel) and representative pictures (right panel) of fiber cross sectional area distribution in
WT (black line) and PHD1KO (red line) TA muscle. f Force–frequency curve in ex vivo stimulated soleus from WT (black line) and PHD1KO (red line) male
mice. g mRNA expression levels of genes involved in ubiquitin-proteasome mediated protein degradation in TA muscle from WT (white bars) and PHD1KO
(red bars) female mice. h Representative pictures and quantification of western blot analysis of LC3B and P62 protein levels in TA muscle from WT (white
bars) and PHD1KO (red bars) female mice. Statistics: two-way ANOVA test, with a Holm–Sidak post hoc test (e, f) or unpaired t test (a, b, c, d, g, h) (*p <
0.05; **p < 0.01; ***p < 0.001; ns not significant). Each dot represents a single mouse (a, b, c, d, h). Bar graphs and line graphs represent mean ± SEM (error
bars). Data is represented as fold change to WT (g, h). EDL m. extensor digitorum longus, GAS m. gastrocnemius, TA m. tibialis anterior. See also
Supplementary Fig. 1. Source data are provided as a Source Data file.
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PHD1 is required for leucine mediated mTORC1 activation.
mTORC1 represents a main regulatory hub in the control of
muscle protein synthesis in response to many anabolic signals,
such as growth factors, eccentric contractions, and/or amino
acids11,38. To study whether loss Phd1 affects amino acid medi-
ated activation of mTORC1 in muscle, we administered L-leucine
(leucine), the most potent amino acid stimulator of mTORC1 and
required for activation of muscle protein synthesis in vivo39, to
PHD1KO and WT animals via oral gavage and subsequently
analyzed mTORC1 activity. In WT TA muscle, leucine admin-
istration activated mTORC1, as judged by the increased phos-
phorylation states of its substrates S6 kinase 1 (p-S6K1), S6
ribosomal protein (p-RPS6), and the 4E-binding protein 1 (p-4E-
BP1) (Fig. 2a and Supplementary Fig. 2a). In contrast, leucine-
mediated phosphorylation of these mTORC1 substrates was
abrogated in PHD1KO muscle (Fig. 2a and Supplementary
Fig. 2a). Immunofluorescent quantification of p-RPS6 levels in
TA muscle confirmed these observations (Fig. 2b, c). Inhibition of
leucine mediated mTORC1 activation upon deletion of Phd1 was
observed in both females (Fig. 2a) as well as males (Supplemen-
tary Fig. 2a), so both genders were used for subsequent experi-
ments. Moreover, inhibition of mTORC1 activity upon loss of
Phd1 is fiber type independent, because we observed impaired
mTORC1 activation in soleus, which is predominantly composed
of a slower fibers, as well as EDL, which contains more fast
glycolytic fibers (Supplementary Fig. 2b, c). To confirm that
impaired mTORC1 activation resulted into impaired protein
synthesis, we used SunSET analysis and measured puromycin
incorporation into muscle protein after leucine injection. This
data showed 50% lower protein synthesis in PHD1KO muscle
when compared to WT (Fig. 2d).
Growth factors such as insulin but also eccentric contractions are
also potent regulators of mTORC1 in the muscle38,40, albeit via
different and independent upstream mechanisms41. To explore
whether PHD1 also controls insulin mediated activation of
mTORC1, we injected mice with insulin (0.2 IU/g) and assessed
mTORC1 activation. We first confirmed that insulin effectively
activated the insulin signaling cascade by assessing the phosphor-
ylation of AKT at Ser473 (p-AKT) (Supplementary Fig. 2d). In
addition, insulin equally increased p-S6K1 in WT and PHD1KO
animals, indicating that PHD1 controls leucine, but not insulin,
mediated activation of mTORC1 (Supplementary Fig. 2d). We
subsequently isolated EDL muscle from PHD1KO andWT mice and
subjected them to an ex vivo eccentric contraction protocol which is
known to activate mTORC1 directly42 or via the inactivation
TSC211. Eccentric contractions effectively activated the stress-
responsive C-Jun N-terminal kinase (JNK), a key regulator of
adaptive remodeling after resistance training43 in both WT and
PHD1KO mice (Supplementary Fig. 2e). Moreover, eccentric
contractions induced a similar activation of mTORC1 downstream
signaling in both WT and PHD1KO mice (Supplementary Fig. 2e).
Thus, PHD1 controls leucine mediated, but not insulin nor
contraction mediated activation of mTORC1 in the muscle.
Growth factors as well as eccentric contractions activate
mTORC1 mainly through the inhibition of its inhibitory TSC
complex11,44, the latter being a direct target of HIF-dependent
inhibition of protein synthesis via REDD115. Moreover, lack of
oxygen availability leads to an AMPK dependent phosphorylation
of the TSC complex as well as RAPTOR45, leading to a general
inhibition of protein synthesis. We did not find increased AMPK
activation (Fig. 2e) nor phosphorylation of TSC2 at Ser1387
(Fig. 2f) in PHD1KO muscle. We also did not pick up increased
expression of the HIF target Redd1 (Fig. 2g). Our data suggest
that PHD1 controls mTORC1 via selectively altering its response
to leucine. We thus decided to further explore the role of PHD1
in leucine metabolism.
PHD1 controls muscle mass in a cell-autonomous fashion. To
study whether the blunted leucine mediated mTORC1 activation
upon Phd1 deletion was driven by muscle-intrinsic factors, we
decided to cross Phd1fl/fl mice with human skeletal muscle α-actin
(HSA)-Cre-ERT2 mice46, which upon tamoxifen treatment results
into the generation of muscle specific Phd1 knockout mice
(PHD1mKO) (Fig. 3a). To evaluate the efficiency of our tamoxifen
regimen, we also crossed HSA-Cre-ERT2 mice with RosamTmG
mice47, a double fluorescent Cre reporter line that expresses
membrane-targeted Tomato (mT) prior to Cre-mediated excision
and GFP (mG) after excision, and confirmed efficient recombi-
nation which was restricted to skeletal muscles (Supplementary
Fig. 3a). Indeed, one week after the last tamoxifen injection, Phd1
mRNA levels in muscle of PHD1mKO mice were around 90%
lower when compared to littermate controls (Fig. 3b).
We next confirmed that loss of Phd1 in muscle suffices to blunt
the activation of mTORC1 downstream targets following leucine
but not insulin stimulation (Fig. 3c and Supplementary Fig. 3b).
Moreover, leucine-induced protein synthesis assessed via puromy-
cin incorporation was reduced as well (Supplementary Fig. 3c). To
further confirm the cell autonomous role of PHD1 in the control of
leucine mediated mTORC1 activation, we isolated muscle stem cells
from WT and PHD1KO mice and differentiated them to myotubes.
Myotubes were starved of amino acids and stimulated with leucine.
In WT myotubes, leucine dose dependently activated mTORC1,
and maximal activation was reached at 5mM (Fig. 3d). Loss of
Phd1 reduced the mTORC1 response at all leucine concentrations
tested (Fig. 3d). Off note, we also measured lower mTORC1 activity
under full medium conditions (containing 0.8mM leucine), but
consistent with our in vivo data, the response to insulin was
preserved (Supplementary Fig. 3d).
PHD1 controls mTORC1 in a hydroxylation-independent
manner. PHDs can control the stability of proteins by hydro-
xylating proline residues which targets them for proteasomal
degradation48,49. To evaluate whether PHD1 controls mTORC1
activity via hydroxylation dependent or independent mechanisms,
we transduced primary satellite cells from PHD1KO mice with
retroviruses to reintroduce either the full length PHD1 (PHD1WT)
or a catalytically inactive PHD1 mutant (PHD1MUT)50. Intro-
duction of PHD1WT as well as PHD1MUT in PHD1KO myotubes
restored leucine-dependent mTORC1 activation (Fig. 3e), showing
that PHD1 controls leucine-mediated mTORC1 activation in a
hydroxylation-independent manner. Based on these observations,
we decided to evaluate how PHD1 controls leucine mediated
mTORC1 activation and hypothesized that this could occur
through regulating leucine uptake or through interacting with
leucine sensing mechanisms10,13.
Loss of Phd1 does not impair leucine uptake. To act on
mTORC1 and induce growth, large neutral amino acids such as
leucine, enter the cell via coupled amino acid transport51. Since
leucine stimulated mTORC1 activation was blunted in PHD1KO
muscle, we investigated whether leucine uptake was impaired in
PHD1KO mice. First, we evaluated expression levels of main
muscle amino acid transporters Snat, Pat1, and Lat1, but these
were unaffected in PHD1KO mice (Fig. 3f). Second, oral admin-
istration of leucine did not alter blood leucine levels (Fig. 3g).
And lastly, we measured leucine uptake into the muscle using 1.5
µCi L-[14C(U)]-leucine tracer labeling. Uptake of 14C-leucine by
GAS and TA muscle was identical between WT and PHD1KO
mice (Fig. 3h). This data shows that leucine transport is not
impaired in PHD1KO mice, and that reduced leucine mediated
activation of mTORC1 is likely due to defects in the intracellular
leucine-mTORC1 activation cascade.
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Fig. 2 PHD1 is required for leucine-mediated mTORC1 activation in vivo. a Representative pictures (left panel) and quantification (right panels) of
western blot analysis of S6K1, RPS6, and 4E-BP1 phosphorylation in TA muscles from WT (white bars) and PHD1KO (red bars) female mice 30min after
saline or leucine gavage. Representative pictures b and quantification c of p-RPS6 immunofluorescence analysis in TA muscle of WT (white bars) and
PHD1KO (red bars) mice 30min after saline (saline) or leucine (leucine) gavage. Intensity measurements are provided in arbitrary units (AU). d
Representative pictures and quantification of western blot analysis of puromycin incorporation in TA muscle fromWT (n= 4) and PHD1KO male mice (n=
4) 30min after leucine gavage. Rapamycin (rapam) was used as a negative control. Representative pictures (top panel) and quantification (bottom panel)
of western blot analysis of AMPK phosphorylation (e) and TSC2 phosphorylation (f) in TA muscle from WT (white bars) and PHD1KO (red bars) mice 30
min after leucine gavage. g Redd1 mRNA expression levels in TA muscle from WT (white bars) and PHD1KO (red bars) female mice. Statistics: two-way
ANOVA test with a Holm–Sidak post hoc test (a, c) or unpaired t test (e–g) (*p < 0.05; **p < 0.01; ***p < 0.001; ns not significant). Each dot represents a
single mouse. Bar graphs represent mean ± SEM (error bars). Data are represented as fold change to WT saline (a, c, e, f) or fold change to WT (g). TA m.
tibialis anterior. See also Supplementary Fig. 2. Source data are provided as a Source Data file.
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PHD1 controls intracellular leucine sensing through LRS.
Upon entering the cell, leucine is “sensed” by SESNs and LRS
which transmit intracellular leucine availability towards
mTORC117,18,22. To investigate whether PHD1 controls leucine
mediated mTORC1 activation via affecting LRS or SESN1–2, we
assessed protein levels of LRS and SESN1–2 in muscle. Interest-
ingly, LRS protein levels were lower both in PHD1KO as well as
PHD1mKO muscle when compared to WT animals (Fig. 4a and
Supplementary Fig. 4a). In contrast, SESN1 nor SESN2 protein
levels were affected by loss of Phd1 (Fig. 4b–d and Supplementary
Fig. 4b–d).
To further investigate the role of LRS and SESNs, we evaluated
whether Sesn knockdown or LRS overexpression could rescue
leucine-dependent mTORC1 activation in Phd1-deficient myo-
tubes. Silencing Sesn1 nor Sesn2 changed the responsiveness to
leucine PHD1KO myotubes (Supplementary Fig. 4e–h).
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Conversely, lentiviral overexpression of LRS in PHD1KO
myotubes restored LRS protein content and increased mTORC1
activation upon leucine stimulation (Fig. 4e). This data indicates
that LRS, but not SESN1–2, is involved in PHD1-mediated
mTORC1 activation in muscle cells. We therefore decided to
focus on LRS and study its role in leucine-dependent mTORC1
activation in muscle.
LRS belongs to a family of proteins known as aminoacyl tRNA
synthetases whose canonical function is to ensure that the genetic
code is accurately deciphered by attaching the correct amino acid
to the equivalent tRNA20. However, LRS also serves as a leucine
sensor for mTORC1 by functioning as a GTP activating protein
for RagD52, thereby promoting lysosomal translocation of
mTORC1. GTP-bound RagD subsequently promotes the LRS-
dependent leucylation of RagA at K142 (KLeu 142) upon leucine
stimulation21. Whether LRS levels are controlled by metabolism
is, however, not clear. In fact, the leucine sensing ability of LRS in
muscle is not described. To confirm that LRS is required for
leucine mediated mTORC1 activation in myotubes, we inhibited
the interaction of LRS with RagD by using BC-LI-018652 and
confirmed reduced leucine mediated activation of mTORC1
(Supplementary Fig. 4i). This data shows that LRS is involved in
leucine-dependent mTORC1 activation in muscle cells.
To confirm that PHD1 reduces LRS downstream signaling to
mTORC1, we stimulated WT and PHD1KO myotubes with
leucine and evaluated RagA KLeu142 levels. In Phd1-deficient
myotubes, leucine failed to increase RagA KLeu142 (Fig. 4e).
Moreover, we observed reduced RagA KLeu142 levels in vivo
(Fig. 4f). We also monitored the lysosomal localization of mTOR
by performing immunofluorescent stainings for mTOR and the
lysosomal marker LAMP2 under starved and stimulated condi-
tions. Whereas we saw a clear increase in LAMP2/mTOR
colocalization in WT myotubes upon (amino acid) stimulation,
increased colocalization was not observed in PHD1KO myotubes
(Fig. 4g, h). The data shows that loss of Phd1 reduces LRS protein
content, leading to impaired mTORC1 translocation to the
lysosomes and impaired RagA KLeu142.
PHD1 interacts with LRS and controls LRS stability. Although
PHDs are mainly known for their hydroxylation dependent
functions, it has been shown that they interact with other proteins
to modulate their stability and/or activity via hydroxylation-
independent mechanisms34. To study whether PHD1 and LRS
interact, we overexpressed both PHD1-flag and LRS-myc in HEK
293T cells and found that LRS and PHD1 coimmunoprecipitated
(Fig. 5a). The ability to interact with LRS was independent of
PHD1’s enzymatic activity, since PHD1MUT also interacted with
LRS (Fig. 5a). Furthermore, we performed an in vitro hydro-
xylation assay using recombinant PHD1 and LRS53 using HIF1α
as a positive control, but did not detect any hydroxylated prolines
on LRS, whereas HIF1α was clearly hydroxylated under the same
experimental conditions (Fig. 5b and Supplementary Fig. 5a).
Interestingly though, whereas the interaction between PHD1
and LRS was weak under normal culture conditions, it was
further promoted when the enzymatic activity of PHD1 was
inhibited upon treatment with the hypoxia mimetic, dimethyl 2-
oxoglutarate (DMOG), or during amino acid starvation (Fig. 5c).
Based on these observations, we wondered whether the interac-
tion between PHD1 and LRS improves LRS stability and whether
LRS stability is enhanced when the interaction is promoted, such
as during nutrient and oxygen deprivation. We first performed a
cycloheximide chase assay for LRS in WT vs. PHD1KO myotubes,
and noticed that upon translation elongation inhibition, LRS
levels dropped faster when Phd1 is absent, indicating that loss of
Phd1 reduces LRS protein stability (Fig. 5d). Second, we found
that LRS protein levels remain remarkably stable (or even
increase) during short-term amino acid starvation as well as
hypoxia in WT myotubes, but rapidly go down in PHD1KO
myotubes (Fig. 5e, f and Supplementary Fig. 5b, c) showing that
PHD1 is required for the maintenance of LRS stability during
oxygen and amino acid deprivation. Altogether, we show that
upon metabolic stress, including amino acid starvation and
hypoxia when PHD1 enzymatic activity is inhibited, PHD1
interacts with LRS and protects it from degradation in a manner
which does not require its enzymatic activity. The protection of
LRS during low oxygen and amino acid levels ensures a rapid and
efficient activation of mTORC1 as soon as nutrient levels are
restored.
PHD1 levels and LRS activity decline during aging. Aging is
associated with a loss of muscle mass. Moreover, the ability of
older muscle to efficiently activate protein synthesis in response
to amino acids, a condition termed anabolic resistance, is
impaired54–56. Several molecular mechanisms underlying ana-
bolic resistance have been proposed, including reduced amino
acid delivery and uptake into the muscle57, but it is not known
whether leucine sensing mechanisms are affected. Thus, to
explore the relevance of our findings in a human setting, we
compared PHD1 protein content in muscle samples from a small
cohort where samples were obtained from healthy old (n= 8, 4
women and 4 men, 72.6 ± 2.3 y (mean ± SEM)) vs. young (n= 8,
4 women and 4 men, 26.1 ± 1.1 y) volunteers after an overnight
fast55. In this cohort, old people showed reduced activation of
muscle protein synthesis in response to milk protein (containing
a high dose of leucine) ingestion when compared to young sub-
jects55. We found that older muscle on average showed an almost
50% decrease in PHD1 levels (Fig. 6a). Lower PHD1 content was
confirmed using immunofluorescent stainings (Fig. 6b, c).
Fig. 3 PHD1 controls muscle mass in a cell-autonomous fashion. a Schematic representation showing the generation of muscle specific Phd1 deficient
mice (PHD1mKO) and the experimental protocol. b Phd1 mRNA expression in TA muscle from WT (white bars) and PHD1mKO (blue bars) male and female
mice. c Representative pictures (left panel) and quantification (right panels) of western blot analysis of p-S6K1, p-RPS6, and p-4E-BP1 in TA muscles from
WT (white bars) and PHD1mKO (blue bars) male and female mice 30min after saline or leucine gavage. d Representative pictures (left panel) and
quantification (right panel) of western blot analysis of p-S6K1 in differentiated myotubes from WT (white bars) and PHD1KO (red bars) mice after 1 h
starvation (strv or starved) or stimulated with increasing concentrations of leucine for 30min (leucine). e Representative pictures (left panel) and
quantification (right panel) of western blot analysis of p-S6K1 and PHD1 expression in differentiated WT (with bars), PHD1KO (red bars), PHD1KO +
PHD1OE-WT (light gray bars) and PHD1KO+ PHD1OE-MUT (dark gray bars) myotubes after 1 h starvation (starved) or 1 h starvation followed by 30min
stimulation with 5mM leucine (leucine). fmRNA expression of different leucine transporters in TA of WT (white bars; n= 8) and PHD1KO (red bars n= 7)
female mice. g Blood leucine in WT (white bars) and PHD1KO (red bars) mice 30min after saline or leucine gavage. h Muscle leucine uptake in GAS and
TA from WT (white bars) and PHD1KO (red bars) female mice 30min after leucine gavage. Statistics: two-way ANOVA with a Holm-Sidak post-hoc test
(c, e) or unpaired t test (b, d, f, g, h) (*p < 0.05; **p < 0.01; ***p < 0.001; ns not significant). Each dot represents a single mouse (b, c, g, h) or means of
independent experiments (d, e). Bar graphs represent mean ± SEM (error bars). Data is represented as fold change to WT saline (c), to WT leucine 5mM
(d, e) or to WT (b, f). See also Supplementary Fig. 3. Source data are provided as a Source Data file.
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Importantly, in other cell types PHD1 localizes mainly in the
nucleus58,59, but several groups have also reported cytosolic
localization60,61 and function of PHD162. We saw clear cytosolic
localization of PHD1 in muscle fibers whereas nuclear staining
was detected, but to a much lower extent. LRS levels were also
lower but this failed to reach statistical significance because
variability between subjects was larger (Fig. 6a). Notwithstanding,
we found a clear reduction in LRS induced leucylation of RagA
(RagA KLeu142) (Fig. 6d), and RagA KLeu142 levels correlated
with PHD1 levels (r= 0.56; p= 0.02). Thus, in aged humans,
impaired activation of muscle protein synthesis in response to
leucine coincides with reduced PHD1 content and LRS activity.
*
ns
*
0.0
**
*
ns
ns
p-
S6
K1
/lo
ad
in
g *
***
a b
ih
f g
c d
e
30
WT
WT
PHD1KO
PHD1KO
20
10
0
LA
M
P2
-m
TO
R
co
lo
ca
liz
at
io
n 
(%
 ar
ea
) 
Strv StrvStim Stim
1
2
0
Load.
– +
K L
eu
 
14
2/
lo
ad
in
g
K L
eu
 
14
2/
lo
ad
in
g
Starved 0.8 5
Leucine (mM)
3.0
1.5
**
ns
KLeu142 KLeu142
Loading
PHD1KO PHD1KO– +– + – +– + – +– +
Starved 0.8 5
Leucine (mM)
WT
PHD1KO
WT
PHD1KO
PHD1KO+ EV
PHD1KO+ LRSOE
1.5
1.0
0.5
0.0
Starved Leucine Starved Leucine
p-S6K1
myc-LRS
Loading
PHD1KO
LRSOE
+ + + + + +– –
+– – – – – – +
Empty vector +– – – – – –+
Starved Leucine
3
2
PHD1mKO
WT
LRS
Loading
PHD1mKO – + – +
SESN2
Loading
– + – + – +– + – +
SESN1
Loading 1
0
LRS SESN1 SESN2
Pr
ot
ei
n/
lo
ad
in
gKDa
5050100
KDa
50
100
KDa
25
25
KDa
KDa KDa
5 μm 5 μm 5 μm 5 μm
5 μm 5 μm 5 μm 5 μm
5 μm 5 μm 5 μm 5 μm
5 μm 5 μm 5 μm 5 μm
St
ar
ve
d
W
T
mTOR LAMP2 Merged Analysis
St
im
ul
at
ed
W
T
PH
D
1K
O
PH
D
1K
O
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13889-6
8 NATURE COMMUNICATIONS |          (2020) 11:174 | https://doi.org/10.1038/s41467-019-13889-6 | www.nature.com/naturecommunications
Discussion
Protein synthesis is a highly energy consuming process which in
many cell types is inhibited during low oxygen and nutrient
availability28,63,64. On the other hand, mechanisms that allow
(and even promote) protein synthesis during hypoxia have also
been described as stabilization of HIF2α promotes mTORC1
activation during low amino acid availability by increasing the
expression of the amino acid carrier Lat129. In fact, in vivo data in
lung and liver during hypoxia have indicated that HIF2α medi-
ated activation of mTORC1 can prevail over HIF1α dependent
mTORC1 inhibition29. It is therefore likely that control of
mTORC1 oxygen sensitive mechanisms is dependent on the
cellular context. Here, we describe that the oxygen sensor PHD1
promotes mTORC1 activation upon leucine stimulation. We
found that PHD1 interacts with the leucine sensor LRS and
controls LRS stability. This interaction is promoted under con-
ditions of hypoxia and amino acid starvation when PHD1
hydroxylation activity is inhibited and protects LRS from degra-
dation. Consequently, loss of Phd1 reduces the stability of LRS,
impairs leucine-mediated activation of mTORC1 and leads to
lower muscle mass in vivo.
We found that PHD1KO mice have lower muscle mass, muscle
fiber size, and force production. This was not caused by increased
muscle proteolysis as we did not find upregulation of atrogenes
nor activation of autophagy. Instead, we observed a blunted
mTORC1 activation in response to leucine stimulation leading to
lower protein synthesis. mTORC1 plays a central role in the
regulation of muscle mass: activation of mTORC1 induces muscle
hypertrophy65,66, whereas skeletal muscle specific inactivation
results in low muscle mass coinciding with dystrophy38. Fur-
thermore, the fact that sustained activation of mTORC1 in
muscle also induces myopathy characterized by muscle atrophy
and weakness67, indicates that mTORC1 activity should be tightly
controlled in order to prevent muscle dysfunction. We did not
find any evidence for muscle dystrophy or myopathy, showing
that the ability of PHD1 to control mTORC1 activity is modest,
and is restricted to modulating upstream anabolic events that
activate mTORC1. Several anabolic signals such as leucine,
growth factors, but also eccentric contractions are potent reg-
ulators of mTORC1 in muscle38,40,68. The activation of mTORC1
in response to growth factors (such as insulin) as well as con-
tractions was however preserved in PHD1KO mice. Instead, there
was a selective “resistance” of PHD1KO muscle toward leucine,
showing that PHD1 controls mTORC1 via events upstream of
mTORC1 which are specifically linked to the sensing and trans-
mission of amino acid signals.
Ample literature has shown the contribution of LRS and SESNs
to leucine sensing in vitro17,18. However, their functional role as
leucine sensors in vivo in tissues such as skeletal muscle, has been
questioned since the Kd dissociation constant for leucine of both
SESN2 and LRS is approximately tenfold lower than the leucine
concentration observed in skeletal muscle of humans22,69,70. This
implies that both enzymes are completely saturated at physiolo-
gical leucine concentrations and has led to the suggestion that
alterations in protein levels of leucine sensors impose an addi-
tional level of control in modulating mTORC1 activity22. On the
other hand, in vitro experiments in HEK293T cells demonstrated
that leucylation of RagA, considered as a readout of LRS activity,
increases in an almost linear manner with leucine doses up to 30-
fold of the normal physiological values21. Thus, the exact
mechanisms through which leucine sensors control mTORC1 still
remain to be fully elucidated. We show here that altering LRS
levels suffices to increase leucine mediated mTORC1 activation in
myotubes. Moreover, we found decreased LRS levels and lower
leucylation of RagA (RagA KLeu142) in PHD1KO animals,
showing that LRS protein levels and LRS activity can be modu-
lated in vivo to/and control mTORC1 activation.
It has been reported that LRS levels remain stable during
amino acid starvation71. This is in agreement with our data. In
addition, we show that PHD1 is required to maintain LRS protein
stability during conditions of oxygen and amino acid deprivation.
The increased stability of LRS is in sharp contrast to most amino
acid tRNA synthetases, which are rapidly degraded during amino
acid starvation induced autophagy72. These observations suggest
that the maintenance of LRS protein levels may not be related to
its role as a tRNA synthetase but with other noncanonical LRS
functions. Instead, keeping LRS levels high during episodes of low
oxygen and/or amino acid availability may allow the cell to ensure
a fast and efficient reactivation of mTORC1 as soon as oxygen
and nutrient levels are restored. Our data also shows active
modulation of LRS levels by metabolism.
We did not observe differences in SESN1–2 protein content
upon loss of Phd1, nor did we observe a rescue of leucine
mediated mTORC1 activation upon knockdown of SESN1–2 in
PHD1KO cells. It is important to mention that these data do not
exclude a role for SESNs in regulating leucine mediated mTORC1
activation in muscle. SESN2 knockout mice also show preserved
mTORC1 activation in response to insulin, but the response to
leucine stimulation has not been evaluated73. Moreover, while
recent evidence indicates that SESN1, rather than SESN2, is
abundantly expressed in muscle and dissociates from GATOR2 in
response to oral leucine administration69, its functional role in
mediating mTORC1 activity upon leucine administration is not
known. Whether or not SESNs directly interact with other
members of the oxygen sensing machinery remains an out-
standing question.
Fig. 4 PHD1 controls intracellular leucine sensing through leucyl tRNA synthetase. a–c Representative pictures and quantification (d) of western blot
analysis of LRS, SESN1, and SESN2 protein levels in TA muscles from WT (white bars) and PHD1mKO male and female (blue bars) mice. e PHD1KO
myogenic progenitors were transduced with lentiviruses to over-express myc-LRS (LRSOE), an empty vector (EV) was used as control. Representative
pictures (left panel) and quantification (right panel) of western blot analysis of S6K1 phosphorylation and myc-LRS expression levels in differentiated WT
(white bars), PHD1KO (red bars), PHD1KO+ EV (light gray bars) and PHD1KO+ LRSOE myotubes (dark gray bars) after 1 h starvation (starved) or 30min
stimulation with 5 mM leucine (leucine). f Representative picture (left panel) and quantification (right panel) of western blot analysis of RagA leucylation
(KLeu142) levels in WT (white bars) and PHD1KO (red bars) myotubes after 1 h starvation (starved) or 30min stimulation with different doses of leucine
(leucine). g Representative picture (left panel) and quantification (right panel) of western blot analysis of RagA leucylation (KLeu142) levels in TA fromWT
(white bars) and PHD1KO (red bars) female mice. Representative pictures (h) and quantification (i) of colocalization between mTOR (red) and LAMP2
(green) in WT (white bars) and PHD1KO (red bars) myotubes. Merged (gray) picture shows the outline of the colocalization analysis between mTOR and
LAMP2 that was performed to generate data shown in panel (i). Dots represent quantification of individual myotubes from three independent experiments.
Statistics: two-way ANOVA test with a Holm–Sidak post hoc test (e, i) or unpaired t test (d, f, g) (*p < 0.05; **p < 0.01; ***p < 0.001; ns not significant).
Each dot represents a single mouse. Dots represent experimental duplicates from four independent experiments (e, f). Bar graphs represent mean ± SEM
(error bars). Data is presented as fold change to WT starved (e, f) or fold change to WT (d, g). See also Supplementary Fig. 4. Source data are provided as
a Source Data file.
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PHDs are key proteins mediating oxygen sensing in cells31,32.
Besides oxygen, PHDs also use αKG, ascorbic acid and Fe2+ as
cofactors to hydroxylate their targets at specific proline resi-
dues32. The enzymatic activity of PHDs is lost when one of these
co-factors is insufficiently available, such as during hypoxia and/
or nutrient deprivation74,75. While HIFs are the best character-
ized targets of PHD hydroxylation activity, more PHD (hydro-
xylation dependent or independent) targets have been
reported34,76. In fact, photosynthetic organisms, which produce
but do not oxidize oxygen for energy production, have been
reported to lack HIFs but not PHDs77 demonstrating potential
HIF-independent functions of PHDs74.
Our data indicates that PHD1 controls leucine mediated
mTORC1 activation in a HIF-independent fashion. First, we did
not see transcriptional activation of Redd1 in PHD1KO muscle, a
previously described HIF1α-target gene which inhibits
mTORC115,33,63, nor did we find differences in phosphorylation
of its downstream target TSC2. Second, most described hypoxia
dependent mechanisms which inhibit mTORC1 have been
shown to act via TSC2 (or in the case of AMPK, via RAPTOR
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Fig. 5 PHD1 interacts with LRS and controls LRS stability. a HEK293T cells were transfected with myc-LRS, myc-LRS and flag-PHD1WT or myc-LRS and
flag-PHD1MUT. Cell lysates were immunoprecipitated with anti-flag antibody. Co-precipitation of myc-LRS was determined by western blot analysis using
an anti-myc antibody. The figure shows a representative experiment. b In vitro hydroxylation assay using 3H-labeled in vitro translated LRS (gray bar) or
HIF1α (white bar; positive control) in the presence of affinity purified PHD1. c HEK293T cells were transfected with myc-LRS or myc-LRS and flag-PHD1WT
and treated with DMOG or amino acid starved for 4 h. Cell lysates were immunoprecipitated with anti-flag antibody. Co-precipitation of myc-LRS was
determined by western blot analysis using an anti-myc antibody. The figure shows a representative experiment. d Representative picture (left panel) and
quantification (right panel) of western blot analysis of LRS protein levels in WT (black line) and PHD1KO (red line) myotubes exposed to cycloheximide
(Chx) for different amounts of time. Dots represent the mean from 2 independent experiments. e Time-course analysis of LRS protein levels in WT (black
line) and PHD1KO (red line) myotubes exposed to amino acid starvation. Dots represent the mean from three independent experiments. f Time-course
analysis of LRS protein levels in WT (black line) and PHD1KO (red line) myotubes exposed to hypoxia (1% oxygen). Dots represent the mean from 3
independent experiments. Statistics: two-way ANOVA (in e and f, interaction effects are indicated) with a a t test (d) (*p < 0.05; **p < 0.01; ***p < 0.001;
ns not significant). Bar graphs and line graphs represent mean ± SEM (error bars). Data are presented as fold change to WT 0 h (d, e, f). See also
Supplementary Fig. 5. Source data are provided as a Source Data file.
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directly)30,33,45. Preserved activation of mTORC1 by insulin
(acting via TSC2) as well as contractions (acting via TSC2 or
RAPTOR directly) strongly argues against involvement of TSC2
or RAPTOR itself. And last, in agreement with our observations,
in vitro reports have shown that PHD dependent control of
mTORC1 upon leucine stimulation can occur independent of
HIFs/TSC274,78. Indeed, DMOG treatment of amino acid starved
MEFs did not result into accumulation of HIF1α or an increase in
HIF transcriptional activity. In addition, DMOG treatment also
prevented mTORC1 activation in both TSC2 knockout MEFs,
suggesting that PHDs act through the Rag GTPases.
The ability of PHD1 to ensure mTORC1 activity upon leucine
stimulation was independent of its hydroxylation activity, since
reintroduction of the catalytic dead PHD1 in PHD1KO myotubes
completely restored mTORC1 activity. Second, we found that
PHD1 interacted with LRS and this interaction also did not
require PHD1 hydroxylation activity because the enzymatic dead
mutant PHD1 also interacted with LRS. Due to different levels of
overexpression for wild type vs. mutant PHD1 within our
immunoprecipitation experiments, it is difficult to make a clear
statement on whether inhibition of the enzymatic activity of
PHD1 suffices to actively promote the interaction or whether
other unknown processes are involved. Nonetheless, we found
that reducing PHD activity by using DMOG as well as amino acid
starvation increased the interaction with LRS and preserved LRS
stability in WT cells. Consequently, loss of Phd1 prevented LRS
stabilization under conditions of amino acid and oxygen shortage,
and resulted into a rapid decline of LRS protein levels. The
detailed mechanisms underlying this improved interaction
require further investigation. Indeed, our data does not allow us
to conclude that the interaction between LRS and PHD1 is
actively promoted when PHD1 hydroxylation activity is inhibited.
An alternative explanation could be that reduced interaction of
PHD1 with its canonical target HIF during hypoxia increases the
availability of PHD1 to interact with other substrates. None-
theless, similar observations were made in breast cancer cells were
the interaction between PHD1 and NRF1/PGC1α to preserve
mitochondrial function during tumor growth was enhanced
during hypoxia and was also independent of PHD1’s hydro-
xylation activity79. Our findings show that PHDs can exert dif-
ferent functions during normoxia/nutrient availability when they
hydroxylate HIFs (and potentially other targets) vs. hypoxia/
nutrient depletion when they execute an autonomous role within
the hypoxia-dependent program.
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Fig. 6 PHD1 levels and LRS activity decline during aging. a Representative picture (left panel) and quantification (right panel) of western blot analysis of
PHD1 and LRS protein levels in m. vastus lateralis biopsies from young (white bars) and old (gray bars) volunteers. Representative immunofluorescent
pictures (b) and quantification (c) of PHD1 (red), Hoechst nuclear staining (blue) and wheat germ agglutinin (WGA, white) in young and old skeletal
muscle. Arrows indicate nuclei. d Representative picture (left panel) and quantification (right panel) of western blot analysis of RagA leucylation (KLeu142)
levels in m. vastus lateralis biopsies from young (white bars) and old (gray bars) volunteers. Statistics: unpaired t test (a) (*p < 0.05; **p < 0.01; ***p < 0.001;
ns not significant). Dots represent values from different volunteers. Bar graphs represent mean ± SEM (error bars). Data is presented as fold change to
young (a, d). Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13889-6 ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:174 | https://doi.org/10.1038/s41467-019-13889-6 | www.nature.com/naturecommunications 11
Altogether, PHD1 integrates oxygen and nutrient availability to
modulate the activation of mTORC1 in response to leucine. The
in vivo relevance of our data is underscored by the lower muscle
mass of PHD1KO animals. Moreover, we observed that PHD1
levels and LRS activity are lower in muscle of elderly with ana-
bolic resistance. To the best of our knowledge, we did not find any
report showing reduced PHD1 levels in aging muscle. The
upstream mediators of altered PHD1 levels during aging are not
known and warrant further research. But since we show that
modulating PHD1/LRS levels can alter the muscular response to
leucine, our data raises the question whether PHD1/LRS levels
could be therapeutically targeted to improve the anabolic effect of
leucine and to prevent the development of age-related sarcopenia.
Methods
Reagents and cell culture. HEK293T cells (DSMZ, ACC 635) were maintained in
DMEM (ThermoFisher Scientific; 41966052) supplemented with 10% fetal bovine
serum (FBS) (ThermoFisher Scientific, 10270-106). Freshly isolated myogenic
progenitors (MPs) were cultured in a 1:1 ratio of DMEM (ThermoFisher Scientific,
12320032) and Ham’s F-10 (1×) nutrient mix (ThermoFisher Scientific, 22390058)
supplemented with 10% horse serum (ThermoFisher Scientific, 16050-122), 20%
FBS and 10 ng/ml basic-FGF (ThermoFisher Scientific, PHG0266). All media were
supplemented with 100 units/ml penicillin and 100 μg/ml streptomycin. Cells were
routinely cultured in 21% O2 and 5% CO2 (normoxic conditions). For hypoxic
exposure, differentiated myotubes were placed into a hypoxia workstation at 1%
O2. All cells were regularly tested for absence of mycoplasma. Lentiviral LRS-
overexpression vector was purchased from Origene (ref number: RC221682L3).
Retroviral vectors to overexpress PHD1 and PHD1-H358A were purchased form
Addgene (catalog numbers: 22704 and 22705, respectively). Lentiviral vectors to
knockdown SESN1 and SESN2 were purchased form Sigma (catalog numbers
SESN1: TRCN0000087808 and SESN2: TRCN0000087791). Cyclohexamide, pur-
omycin, DMOG, and polybrene were from Sigma (c7698, P8833, D3695, and
TR1003)
Isolation and culture of primary MPs: Muscle tissue was digested in HBSS
supplemented with 1.5% bovine serum albumin (BSA) and 2 mg/mL collagenase
type II (ThermoFisher Scientific, 17101015) for 1 h at 37 °C. After centrifugation,
the cell pellet was then filtered using 40 and 100 µm cell strainers and a
heterogeneous cell population was purified by FACS sorting or by serial preplating.
For FACS, MPs were sorted based on positive alpha 7-integrin (1:100) and absence
of Sca1, CD31, and CD45 (1:1000, see Supplementary Table 1). For serial
preplating, a freshly extracted heterogeneous cell population was preplated for 1.5 h
at day 0, 4, and 10 after cell extraction. MPs were cultured in growth medium (see
above) on dishes coated with Matrigel Basement Membrane Matrix (Corning,
#356237, 1/25 dilution). When cells reached 80% confluency, growth medium was
switched to differentiation medium containing low-glucose DMEM, 2% HS and 1%
P/S. MPs were fully differentiated after 3 days.
Leucine stimulation: differentiated myotubes were starved for 1 h in low-glucose
DMEM lacking all amino acids (US Biology, D9800-13), supplemented with 10%
dialyzed FBS (dFBS) (ThermoFisher Scientific, 26400-044). Leucine was supplemented
for 30 min in the indicated concentrations. For the RagA leucylation experiments,
differentiated myotubes were incubated with DMEM containing all AA, except
leucine (Sigma, 9443)+ 10% FBS for 16 h supplemented with 0, 0.8, or 5mM
leucine.
Insulin stimulation: differentiated myotubes were serum starved for 16 h and
100 nM insulin was added to the medium for 5, 10, 20, and 30 min.
Amino acid starvation: differentiated myotubes were starved from all amino
acids in low-glucose amino acids free DMEM (US Biology, D9800-13)
supplemented with 10% dFBS for 0.5, 2, 4, and 24 h.
Cyclohexamide (CHXChx) time-course: differentiated myotubes were treated
with 100 µg/ml Chx (Sigma-aldrich, c7698) for 2, 4, 6, 8, and 10 h.
Viral infections. For lentiviral infections HEK293T cells were transfected with 8 μg
of each lentiviral vector and 5 μg of pmd2.G and pCMV8.9 lentivirus packaging
plasmids using Lipofectamine 2000 (Invitrogen, 11668019). For retroviral infec-
tions, HEK293T cells were transfected with 10 μg of each retroviral vector and
10 μg of pCL-ECO retroviral packaging plasmids. Cell culture supernatants were
harvested 24, 48, and 72 h after transfection, passed through a 0.45 μm pore size
filter, supplemented with 4 µg/µl of polybrene and added to MPs.
In vitro pull-down assay. HEK293T were transfected with Myc-LRS18 and flag-
PHD1 for 72 h and were subsequently lysed (50 mM Tris-HCl, pH 7.4, 10 mM
NaCl, 1 mM EDTA, 0.5 mM EGTA, 1 mM MgCl2, 0.1% CHAPS and 0.5% Triton
X-100 supplemented with protease inhibitors). Cell lysates were centrifuged at
15,000g for 20 min. A total of 300 µg protein from the supernatant fraction was
incubated with ANTI-FLAG® M2 Affinity Gel (Sigma, A2220-1ML) at 4 °C
overnight. After washing 3 times in lysis buffer supplemented with 50 mM NaCl,
the precipitates were dissolved in laemmli buffer.
In vitro hydroxylation assay. The potential ability of PHD1 to hydroxylate LRS
was studied by determining the amount of radioactive 4-hydroxyproline formed in
the substrate. Full-length cDNAs for human LRS and HIF1α (positive control)
were translated in the presence of L-[2,3,4,5-3 H]-proline (85 mCi/mmol, Perkin
Elmer) in a rabbit reticulocyte lysate using a TNT® Quick Coupled Transcription/
Translation System (Promega). The products were analyzed by 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis followed by fluorography.
Totally, 45 μl of the products, containing approximately 2 × 106 cpm of incorpo-
rated radioactive proline, was used as the substrate for the affinity purified PHD180
in a final reaction volume of 0.25 ml under reported conditions80 except that the 2-
oxoglutarate was non-labeled. PHD1 was omitted from the control reactions. The
samples were subsequently dialyzed to remove any remaining free L-[2,3,4,5-3 H]-
proline and the radioactive 4-hydroxyproline formed in the substrate was analyzed
in hydroxylyzed samples by means of a specific radiochemical assay53.
Human muscle samples. Participants were informed of the purpose and metho-
dology of the study prior to providing written informed consent. Ethical approval
was obtained through the NHS Black country Research Ethics Committee (13/WM/
0429)55. The study was performed in agreement with the standards set by the
Declaration of Helsinki (seventh edition). Muscle samples from old (n= 8, 4 women
and 4 men, 72.6 ± 2.3 y) and young (n= 8, 4 women and 4 men, 26.1 ± 1.1 y)
volunteers were obtained fromm. vastus lateralis after an overnight fast. Details from
biopsy procedure and freezing method can found elsewhere55.
Animals. Whole body Phd1 knockout (PHD1KO) mice (50% Swiss/50% 129S1
background) were previously generated35. Phd1fl/fl mice were generated using
homologous recombination in embryonic stem (ES) cells. The targeting vector was
built in a pPNTlox2 plasmid with loxP sites flanking the neomycine resistance
(neor) cassette, and contained from 5′ to 3′: a 5.3-kb EcoRV-HindIII fragment
comprising exon 2 and the majority of intron 2 as 5′ homology arm, a 1.8-kb floxed
neor cassette, a 2.5-kb HindIII-EcoRV fragment comprising exon 3 through 6, in
which a third loxP site was introduced downstream of exon 4 along with a novel
EcoRI site for genotyping purposes, an SV40 thymidine kinase expression cassette
for negative selection purposes. The introduced third loxP site together with the
loxP site located 3′ of the neor cassette thus flanked the Phd1 gene segment
comprising exon 3 and 4, which encode part of the catalytic domain conferring the
prolyl hydroxylase activity. The construct was linearized with NotI and electro-
porated into G4 ES cells of 129SvEv/C57BL6 origin (kind gift from A. Nagy,
Toronto)35. After positive–negative drug selection with 200 µg/ml G418 (Invitro-
gen) and 2 µM Ganciclovir (Sigma Aldrich), resistant clones were analyzed for
correct homologous recombination by appropriate Southern blotting and PCR.
Correctly targeted ES cells were then transiently electroporated with the pOG231
Cre-recombinase expressing plasmid to excise the floxed neor cassette. Clones with
exclusive excision of the neor cassette and retention of the floxed genomic frag-
ment, were identified by PCR and Southern blot screens based on the retention of
the newly introduced EcoRI site. The resulting Phd1+/fl ES cells were then used for
diploid aggregation with Swiss morula embryos to obtain chimeric mice, and
germline Phd1+/fl offspring from crosses of male chimeras with C57BL6/J females
were backcrossed to C57BL6/J mice for 6 generations, to generate Phd1+/fl mice
with a genetic background of >98% C57BL6/J. To generate muscle-specific Phd1
knockout (PHD1mKO) animals, Phd1fl/fl mice (C57BL/6J background) were
crossed with transgenic mice expressing Cre under the control of HSA promotor46
and kept in a homozygous mating system for fl/fl and heterozygous for HSA.Cre-
negative littermates were used as controls. At the age of 10 weeks, mice were
injected with 1 mg tamoxifen for 5 days and a washout period of 9 days was
allowed before experiments were initiated. To generate HSA.iCre-RosamTmG mice,
transgenic mice expressing Cre under the HSA promotor were crossed with het-
erozygous RosamTmG mice47.
Experimental procedures. All animal procedures were approved by the Veter-
inary office of the Canton of Zürich (licence nr. ZH255-16), by the local ethics
committee of the KU Leuven, Belgium (P174-2014) and were executed in com-
pliance with the institutional and national guidelines and regulations. Sample size
was determined based on previous experiments in our lab and similar studies
reported in the literature. All mice used for the experiments were housed 3–4
littermates per cage in individually ventilated cages at standard housing conditions
(22 °C, 12 h light/dark cycle, dark phase starting at 7 pm), with ad libitum access to
chow (18% proteins, 4.5% fibers, 4.5% fat, 6.3% ashes, Provimi Kliba SA) and
water. Health status of all mouse lines was regularly monitored according to
FELASA guidelines.
Leucine and insulin administration in vivo: The morning (8:00 A.M.) of the
experiments, mice were fasted for 4 h. A suspension of 40 g L-leucine/L in distilled
water was freshly prepared and mice were administered 0.4 g L-leucine kg−1 bw−1
via oral gavage. Control mice were administered equal volume saline (0.9% NaCl).
Exactly 30 min after saline or leucine administration, mice were sacrificed and
GAS, SOL, TA, and EDL, were harvested and either snap frozen in liquid N2
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(biochemical analysis) or embedded in Tissue-Tek and frozen in liquid N2 cooled
isopentane (histological analysis). Blood samples were obtained from the tail vain,
centrifuged and serum was stored at −80 °C for further analysis. For insulin
stimulation experiments, 0.2 IU/kg insulin was intraperitoneally injected and
animals were sacrificed for muscle dissection exactly 15 min after.
Muscle force measurements: WT and PHD1KO mice were sacrificed and
soleus was excised and placed in Krebs–Henseleit buffer (120mM NaCl, 4.8mM KCl,
25mM NaHCO3, 2.5 mM CaCl2, 1.2mM KH2PO4, 2mM MgSO4) supplemented
with 1× MEM amino acid mixture (Invitrogen, 11130051) and 25mM glucose. After
15min of equilibration, soleus was attached to the lever arms of an Aurora system
(Aurora Scientific) and submerged in Krebs–Henseleit buffer that was continuously
gassed with 95% O2/5% CO2 and maintained at 37 °C. Muscle length was adjusted
until a single stimulus pulse elicited maximum force during a twitch (Lo) under
isometric conditions. After a 5min rest, a force frequency protocol was initiated by
subsequently providing a pulse train (lasting 250ms) of 1–30–50–80–150–250 and
300 Hz with 1min rest between every intensity. Data were analyzed using the software
provided by the manufacturer.
MRI: body composition was measured in 12–14-week-old PHD1KO mice after
short term food withdrawal (4 h) using EchoMRI-100H (EchoMRI) according to
the manufacturer’s instructions.
Immunohistochemistry and histology. Fiber typing: skeletal muscle sections (10
µm) were dried and washed for 5 min in phosphate-buffered saline (PBS) sup-
plemented with 0.05% triton (PBST) and subsequently blocked for 60 min in PBST
+ 10% goat serum (ThermoFisher Scientific, 16200-064). Afterwards a primary
antibody cocktail was applied for 120 min for myosin heavy chain I (1:50), IIa
(1:200) and b (1:100) (see Supplementary Table 1) diluted in PBST+ 10% goat
serum. After washing 3 times for 5 min, a secondary antibody cocktail, diluted in
PBST+ 10% goat serum, was applied for goat anti-mouse Alexa Fluor 488,350,568
and wheat germ agglutinin Alexa fluor 647 (1:250) (ThermoFisher Scientific, see
Supplementary Table 2) for 60 min. Slides were mounted after a 3 × 5 min wash,
sealed with glass cover slips and imaged with a epifluorescent microscope (Zeiss
Axio observer Z.1) at 10×. Fiber cross-sectional area was automatically determined
with a Muscle J plugin for Image J software81. Muscle fiber type was manually
counted on tile scans. To determine the presence of centrally nucleated fibers,
sections were stained with haematoxylin and eosin.
mTORC1 downstream signaling in mouse skeletal muscle and PHD1 in human
skeletal muscle: 9 µm thin TA sections were fixed −20 °C acetone for 10 min. After
incubating in PBS for 15 min, the sections were then incubated in solution A (PBS
with 5% goat serum and 0.3% CHAPS) for 1 h. After three 5 min washes with PBS,
samples were incubated overnight at 4 °C with PBS with 0.5% BSA and 0.3%
CHAPS containing primary antibodies specific for pS6ser235/236 (1:500) (see
Supplementary Table 1). The next morning, after three 5 min washes in PBS,
samples were incubated for 1 h in solution A with the appropriate 488-conjugated
goat anti-rabbit IgG secondary antibody (1:250, ThermoFisher Scientific, see
Supplementary Table 2). Images were captured with Zeiss Axio observer Z.1.
Exposure times were kept constant for each image and color intensity was set to the
WT saline condition.
LAMP2-mTORC1 colocalization: WT and PHD1KO myoblasts were
differentiated in matrigel-coated (1:25) 8-well chambers (ibidi; 80826). Briefly, fully
differentiated myotubes were untreated, starved for 1 h in HBSS or starved in HBSS
for 1 h and restimulated with differentiation medium for 1 h, after which they were
rinsed with ice-cold (4 °C) PBS once and fixed for 5 min with 4%
paraformaldehyde in PBS. The chamber wells were rinsed twice with PBS and
permealized with 0.2% Triton X-100 in PBS for 15 min. After rinsing twice with
PBS, the wells were blocked for one hour in blocking buffer (0.25% BSA in PBS)
and incubated with primary antibody for LAMP2 and mTOR (1:200) in blocking
buffer overnight at 4 °C (see Supplementary Table 1). Subsequently, the wells were
rinsed twice with blocking buffer and incubated with secondary antibodies (diluted
in blocking buffer 1:500) for one hour at room temperature in dark. Individual
myotubes were imaged with 60× confocal microscope (Olympus olympus fluoview
FV 3000). LAMP2-mTOR colocalization was determined by ImageJ using a plugin
described by Moser et al.82. This analysis combines object based-recognition with
pixel-intensity-correlation. The combined colocalization area (in pixels) of
threshold 1 and 2 was multiplied by Pearson R and divided by the total fiber area.
SuNSET analysis for protein synthesis. WT and PHD1KO mice were gavaged
with 0.4 g L-leucine kg−1 BW−1 and simultaneously IP-injected with 0.040 µmol/g
puromycin (Sigma-Aldrich, P8833) dissolved in 100 µl of PBS. Mice were sacrificed
30 min after injection, muscles were snap-frozen in liquid N2 and stored for further
analysis.
Western blot. Muscle tissue (10–15 mg) was homogenized with a tissue homo-
genizer (Omni THq) in ice cold lysis buffer (1:15 w/v): [50 mM Tris–HCl pH 7.0,
270 mM sucrose, 5 mM EGTA, 1 mM EDTA, 1 mM sodium orthovanadate, 50 mM
glycerophosphate, 5 mM sodium pyrophosphate, 50 mM sodium fluoride, 1 mM
DTT, 0.1% Triton-X 100 and a complete protease inhibitor tablet (Roche Applied
Science)]. The same lysis buffer was used for differentiated myotubes. Homo-
genates were centrifuged at 10,000g for 10 min at 4 °C. Supernatant was collected
and protein concentration was measured using the DC protein assay kit. Totally,
20–40 µg of total protein was loaded in a 15-well pre-casted gradient gel (Bio-rad,
456-8086). After electrophoresis, a picture of the gel was taken under UV-light to
determine protein loading using strain-free technology. Proteins were transferred
via semidry transfer onto a polyvinylidene fluoride membrane (Bio-rad, 170-4156)
and subsequently blocked for 1 h at room temperature with 5% milk in TBS-
Tween. Membranes were incubated overnight at 4 °C with primary antibodies
listed in Supplementary Table 1 (1:500–1:1000). The appropriate secondary anti-
bodies (1:5000) for anti-rabbit and anti-mouse IgG HRP-linked antibodies (Cell
signaling, see Supplementary Table 2) were used for chemiluminescent detection of
proteins. Membranes were scanned with a chemidoc imaging system (Bio-rad) and
quantified using Image lab software (Bio-rad).
RT-qPCR. Muscle tissue (10–15 mg) was homogenized with a tissue homogenizer
(Omni THq) in 1000 µl ice-cold TRIzol (ThermoFisher Scientific, 15596018), and
after addition of 200 µl chloroform, the homogenate was spun down for 15 min at
12,000g. The clear phase was mixed with 70% Ethanol and transferred into a
mRNA extraction column (ThermoFisher Scientific, 12183018A). Subsequently,
mRNA was extracted according to the manufacturer’s instruction. Messenger RNA
of cells was extracted using the same mRNA extraction kit. The purity and quantity
of mRNA was assed via a photospectometer (Tecan, Spark). mRNA was reverse-
transcribed using iSctipt cDNA synthesis kit (Bio-Rad, 170-8891). A SYBER
Green-based master mix (ThermoFisher Scientific, A25778) was applied for real-
time qPCR analysis. Primers that were used are listed in Supplementary Table 3. To
compensate for variations in mRNA input and efficiency of reverse-transcription,
three housekeeping genes were used (GAPDH, β-Actin). The delta–delta CT
method was used to normalize the data.
GC-MS determination of leucine levels. Extractions for subsequent mass-
spectroscopy analysis were prepared and analyzed as previously described83.
Skeletal muscle leucine uptake. After a 6 h fasting period, mice were gavaged
with a bolus of 0.16 g/kg L-Leucine spiked with 1.5 µCi L-[14 C(U)]-Leucine
(PerkinElmer, NEC279E050UC). Blood samples were obtained from the tail vein
before and 3, 6, 10, 15, 20, and 30 min after administration of the solution. Once
the final blood sample was taken, mice were sacrificed and GAS and TA were
quickly dissected and processed for further analysis. Muscles were digested in
0.5 ml 1M NaOH for 30 min at 65 °C, vortexed to assure complete digestion and
neutralized with 0.5 ml 1M HCl. Radioactivity was determined in 400 µl of this
mixture in duplicate or in 5 µl serum by liquid scintillation counting (Beckman LS
6500; Beckman Coulter). The rate of L-leucine uptake (Kin) was calculated by the
equation Kin= total dpm muscle/AUC 0–30 min.
Statistical analysis. A two-way ANOVA design was used to assess the statistical
significance of differences between mean values over phenotype and treatment.
When appropriate, Tukey post hoc test was used. To determine statistical sig-
nificances between two groups, an unpaired student’s t test was used. Level of
significance was set at α= 0.05. Results are shown as mean ± SEM.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data presented in this study are available from the corresponding authors upon
reasonable request. The source data underlying Figs. 1–6 and Supplementary Figs. 1–5
are provided as a Source Data file.
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